Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
nasdaq:aimt | nasdaq:aimt Shareholders | 13F-HR/A | 0000948046-21-000195 | Sep 30th, 2018 12:00AM | Dec 21st, 2021 12:00AM | Dec 21st, 2021 12:00AM | DEUTSCHE BANK AG\ | 948046 | AIMMUNE THERAPEUTICS INC | COM | 00900T107 | 5355 | 196306 | SH | DFND | 168560 | 0 | 27746 | May 5th, 2022 07:58AM | May 5th, 2022 07:58AM | Aimmune Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
nasdaq:aimt | nasdaq:aimt Shareholders | 13F-HR/A | 0000948046-21-000195 | Sep 30th, 2018 12:00AM | Dec 21st, 2021 12:00AM | Dec 21st, 2021 12:00AM | DEUTSCHE BANK AG\ | 948046 | AIMMUNE THERAPEUTICS INC | COM | 00900T107 | 431 | 15805 | SH | DFND | 33 | 0 | 0 | 15805 | May 5th, 2022 07:58AM | May 5th, 2022 07:58AM | Aimmune Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:aimt | nasdaq:aimt Shareholders | 13F-HR/A | 0000948046-21-000195 | Sep 30th, 2018 12:00AM | Dec 21st, 2021 12:00AM | Dec 21st, 2021 12:00AM | DEUTSCHE BANK AG\ | 948046 | AIMMUNE THERAPEUTICS INC | COM | 00900T107 | 2887 | 105833 | SH | DFND | 10 | 105833 | 0 | 0 | May 5th, 2022 07:58AM | May 5th, 2022 07:58AM | Aimmune Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:aimt | nasdaq:aimt Shareholders | 13F-HR/A | 0000948046-21-000195 | Sep 30th, 2018 12:00AM | Dec 21st, 2021 12:00AM | Dec 21st, 2021 12:00AM | DEUTSCHE BANK AG\ | 948046 | AIMMUNE THERAPEUTICS INC | COM | 00900T107 | 876 | 32100 | SH | DFND | 6 | 32100 | 0 | 0 | May 5th, 2022 07:58AM | May 5th, 2022 07:58AM | Aimmune Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:aimt | nasdaq:aimt Shareholders | 13F-HR/A | 0000948046-21-000195 | Sep 30th, 2018 12:00AM | Dec 21st, 2021 12:00AM | Dec 21st, 2021 12:00AM | DEUTSCHE BANK AG\ | 948046 | AIMMUNE THERAPEUTICS INC | COM | 00900T107 | 21 | 763 | SH | DFND | 2 | 763 | 0 | 0 | May 5th, 2022 07:58AM | May 5th, 2022 07:58AM | Aimmune Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:aimt | nasdaq:aimt Shareholders | 13F-HR/A | 0001374170-21-000048 | Sep 30th, 2020 12:00AM | Nov 12th, 2021 12:00AM | Nov 12th, 2021 12:00AM | NORGES BANK | 1374170 | AIMMUNE THERAPEUTICS INC | COM | 00900T107 | 5003 | 145222 | SH | SOLE | 145222 | 0 | 0 | May 5th, 2022 05:20AM | May 5th, 2022 05:20AM | Aimmune Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
nasdaq:aimt | nasdaq:aimt Shareholders | 13F-HR | 0001166588-21-000006 | Sep 30th, 2021 12:00AM | Nov 12th, 2021 12:00AM | Nov 12th, 2021 12:00AM | BNP PARIBAS ARBITRAGE, SA | 1166588 | AIMMUNE THERAPEUTICS INC | EQUITY | 00900T107 | 373782 | 10850 | SH | DFND | 1 | 0 | 10850 | 0 | May 5th, 2022 05:19AM | May 5th, 2022 05:19AM | Aimmune Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:aimt | nasdaq:aimt Shareholders | 13F-HR/A | 0001374170-21-000042 | Jun 30th, 2020 12:00AM | Aug 13th, 2021 12:00AM | Aug 13th, 2021 12:00AM | NORGES BANK | 1374170 | AIMMUNE THERAPEUTICS INC | COM | 00900T107 | 7871 | 471024 | SH | SOLE | 471024 | 0 | 0 | May 4th, 2022 10:15PM | May 4th, 2022 10:15PM | Aimmune Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
nasdaq:aimt | nasdaq:aimt Shareholders | 13F-HR | 0001641866-21-000005 | Jun 30th, 2021 12:00AM | Jul 13th, 2021 12:00AM | Jul 13th, 2021 12:00AM | IFP Advisors, Inc | 1641866 | AIMMUNE THERAPEUTICS INC COM | Stock | 00900T107 | 0 | 0 | SH | SOLE | 0 | 0 | 0 | 0 | May 4th, 2022 07:08PM | May 4th, 2022 07:08PM | Aimmune Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:aimt | nasdaq:aimt Shareholders | 13F-HR/A | 0001172661-21-001416 | Sep 30th, 2020 12:00AM | Jun 21st, 2021 12:00AM | Jun 21st, 2021 12:00AM | CAPSTONE INVESTMENT ADVISORS, LLC | 1426196 | AIMMUNE THERAPEUTICS INC | COM | 00900T107 | 2366 | 68692 | SH | SOLE | 68692 | 0 | 0 | May 4th, 2022 06:09PM | May 4th, 2022 06:09PM | Aimmune Therapeutics | Health Care | Pharmaceuticals & Biotechnology |